Latest Insider Transactions at Candel Therapeutics, Inc. (CADL)
This section provides a real-time view of insider transactions for Candel Therapeutics, Inc. (CADL). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Candel Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Candel Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 24
2024
|
Estuardo Aguilar Cordova > 10% Shareholder |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
50,000
-17.77%
|
$400,000
$8.82 P/Share
|
|
Dec 24
2024
|
Estuardo Aguilar Cordova > 10% Shareholder |
BUY
Sale (or disposition) back to the issuer
|
Direct |
50,000
+15.46%
|
$400,000
$8.82 P/Share
|
|
Dec 23
2024
|
Estuardo Aguilar Cordova > 10% Shareholder |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
50,000
-15.09%
|
$400,000
$8.52 P/Share
|
|
Dec 23
2024
|
Estuardo Aguilar Cordova > 10% Shareholder |
SELL
Sale (or disposition) back to the issuer
|
Direct |
50,000
-13.39%
|
$400,000
$8.52 P/Share
|
|
Dec 20
2024
|
Estuardo Aguilar Cordova > 10% Shareholder |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
100,000
-23.18%
|
$900,000
$9.0 P/Share
|
|
Dec 20
2024
|
Estuardo Aguilar Cordova > 10% Shareholder |
SELL
Sale (or disposition) back to the issuer
|
Direct |
100,000
-21.12%
|
$900,000
$9.0 P/Share
|
|
Dec 16
2024
|
Paul B Manning |
BUY
Open market or private purchase
|
Indirect |
1,250,000
+33.48%
|
$7,500,000
$6.0 P/Share
|
|
Dec 12
2024
|
Estuardo Aguilar Cordova > 10% Shareholder |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
200,000
-31.67%
|
$2,000,000
$10.04 P/Share
|
|
Dec 12
2024
|
Estuardo Aguilar Cordova > 10% Shareholder |
SELL
Sale (or disposition) back to the issuer
|
Direct |
200,000
-29.7%
|
$2,000,000
$10.04 P/Share
|
|
Dec 11
2024
|
Estuardo Aguilar Cordova > 10% Shareholder |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
200,000
-24.05%
|
$1,600,000
$8.53 P/Share
|
|
Dec 11
2024
|
Estuardo Aguilar Cordova > 10% Shareholder |
SELL
Sale (or disposition) back to the issuer
|
Direct |
200,000
-22.9%
|
$1,600,000
$8.53 P/Share
|
|
Dec 06
2024
|
Estuardo Aguilar Cordova > 10% Shareholder |
SELL
Sale (or disposition) back to the issuer
|
Direct |
20,000
-17.96%
|
$100,000
$5.23 P/Share
|
|
Dec 05
2024
|
Estuardo Aguilar Cordova > 10% Shareholder |
SELL
Sale (or disposition) back to the issuer
|
Direct |
20,000
-15.23%
|
$80,000
$4.79 P/Share
|
|
Dec 04
2024
|
Estuardo Aguilar Cordova > 10% Shareholder |
SELL
Sale (or disposition) back to the issuer
|
Direct |
20,000
-13.22%
|
$80,000
$4.46 P/Share
|
|
Nov 29
2024
|
Francesca Barone Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
22,081
-13.8%
|
$88,324
$4.56 P/Share
|
|
Nov 29
2024
|
William Garrett Nichols Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
13,935
-12.17%
|
$55,740
$4.56 P/Share
|
|
Nov 29
2024
|
Paul Peter Tak Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
48,847
-14.21%
|
$195,388
$4.56 P/Share
|
|
Nov 29
2024
|
Seshu Tyagarajan Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
20,392
-13.96%
|
$81,568
$4.56 P/Share
|
|
Nov 25
2024
|
Estuardo Aguilar Cordova > 10% Shareholder |
SELL
Sale (or disposition) back to the issuer
|
Direct |
20,000
-11.67%
|
$80,000
$4.97 P/Share
|
|
Nov 21
2024
|
Paul Peter Tak Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,900
+3.62%
|
$12,900
$1.55 P/Share
|
|
Nov 08
2024
|
Estuardo Aguilar Cordova > 10% Shareholder |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
7,500
-0.89%
|
$30,000
$4.92 P/Share
|
|
Nov 08
2024
|
Estuardo Aguilar Cordova > 10% Shareholder |
SELL
Sale (or disposition) back to the issuer
|
Direct |
7,500
-0.85%
|
$30,000
$4.92 P/Share
|
|
Nov 07
2024
|
Estuardo Aguilar Cordova > 10% Shareholder |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
7,500
-0.89%
|
$37,500
$5.19 P/Share
|
|
Nov 07
2024
|
Estuardo Aguilar Cordova > 10% Shareholder |
SELL
Sale (or disposition) back to the issuer
|
Direct |
7,500
-0.84%
|
$37,500
$5.19 P/Share
|
|
Nov 06
2024
|
Estuardo Aguilar Cordova > 10% Shareholder |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
7,500
-0.88%
|
$37,500
$5.33 P/Share
|
|
Nov 06
2024
|
Estuardo Aguilar Cordova > 10% Shareholder |
SELL
Sale (or disposition) back to the issuer
|
Direct |
7,500
-0.84%
|
$37,500
$5.33 P/Share
|
|
Nov 01
2024
|
Estuardo Aguilar Cordova > 10% Shareholder |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
7,500
-0.87%
|
$37,500
$5.27 P/Share
|
|
Nov 01
2024
|
Estuardo Aguilar Cordova > 10% Shareholder |
SELL
Sale (or disposition) back to the issuer
|
Direct |
7,500
-0.83%
|
$37,500
$5.27 P/Share
|
|
Oct 31
2024
|
Estuardo Aguilar Cordova > 10% Shareholder |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
7,500
-0.86%
|
$37,500
$5.3 P/Share
|
|
Oct 31
2024
|
Estuardo Aguilar Cordova > 10% Shareholder |
SELL
Sale (or disposition) back to the issuer
|
Direct |
7,500
-0.82%
|
$37,500
$5.3 P/Share
|
|
Oct 30
2024
|
Estuardo Aguilar Cordova > 10% Shareholder |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
6,000
-0.69%
|
$30,000
$5.38 P/Share
|
|
Oct 30
2024
|
Estuardo Aguilar Cordova > 10% Shareholder |
SELL
Sale (or disposition) back to the issuer
|
Direct |
6,000
-0.65%
|
$30,000
$5.38 P/Share
|
|
Oct 28
2024
|
Estuardo Aguilar Cordova > 10% Shareholder |
SELL
Sale (or disposition) back to the issuer
|
Direct |
11,711
-1.3%
|
$58,555
$5.58 P/Share
|
|
Oct 25
2024
|
Estuardo Aguilar Cordova > 10% Shareholder |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,597
-0.18%
|
$7,985
$5.8 P/Share
|
|
Oct 24
2024
|
Estuardo Aguilar Cordova > 10% Shareholder |
SELL
Sale (or disposition) back to the issuer
|
Direct |
17,621
-0.96%
|
$88,105
$5.63 P/Share
|
|
Oct 15
2024
|
Estuardo Aguilar Cordova > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
10,412
-1.12%
|
$62,472
$6.03 P/Share
|
|
Oct 14
2024
|
Estuardo Aguilar Cordova > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
15,000
-1.59%
|
$90,000
$6.02 P/Share
|
|
Oct 11
2024
|
Estuardo Aguilar Cordova > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
15,000
-1.56%
|
$90,000
$6.05 P/Share
|
|
Oct 03
2024
|
Estuardo Aguilar Cordova > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
1,800
-0.19%
|
$10,800
$6.85 P/Share
|
|
Oct 02
2024
|
Estuardo Aguilar Cordova > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
26,988
-2.73%
|
$161,928
$6.92 P/Share
|
|
Oct 01
2024
|
Estuardo Aguilar Cordova > 10% Shareholder |
BUY
Open market or private sale
|
Direct |
6,214
+0.62%
|
$43,498
$7.01 P/Share
|
|
Jul 17
2024
|
Paul Peter Tak Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
22,528
-6.38%
|
$135,168
$6.47 P/Share
|
|
Jul 17
2024
|
Seshu Tyagarajan Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
14,851
-9.23%
|
$89,106
$6.47 P/Share
|
|
Jul 17
2024
|
Francesca Barone Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
14,051
-8.07%
|
$84,306
$6.47 P/Share
|
|
Jul 17
2024
|
William Garrett Nichols Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
10,875
-8.68%
|
$65,250
$6.47 P/Share
|
|
Jul 17
2024
|
Charles Schoch |
SELL
Open market or private sale
|
Direct |
9,884
-13.65%
|
$59,304
$6.47 P/Share
|
|
Jul 11
2024
|
Paul Peter Tak Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
20,293
-5.43%
|
$101,465
$5.97 P/Share
|
|
Jul 11
2024
|
Seshu Tyagarajan Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
13,330
-7.65%
|
$66,650
$5.97 P/Share
|
|
Jul 11
2024
|
Francesca Barone Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
12,645
-6.77%
|
$63,225
$5.97 P/Share
|
|
Jul 11
2024
|
William Garrett Nichols Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
9,769
-7.23%
|
$48,845
$5.97 P/Share
|